Genome-wide association analysis identifies three new breast cancer susceptibility loci
Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON)(University of Cambridge), Maya Ghoussaini(Institute of Cancer Research), Familial Breast Cancer Study (FBCS)(University of Cambridge), The Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network(Institute of Cancer Research), kConFab Investigators(The Netherlands Cancer Institute), Australian Ovarian Cancer Study Group(University of Cambridge), Olivia Fletcher(University of Cambridge), Kyriaki Michailidou(University of Cambridge), Clare Turnbull(University of Cambridge), Marjanka K. Schmidt(University of Cambridge), Ed Dicks(University of Cambridge), Joe Dennis(University of Cambridge), Qin Wang(University of Cambridge), Manjeet K. Humphreys(University of Cambridge), Craig Luccarini(University of Cambridge), Caroline Baynes(Institute of Cancer Research), Don Conroy(Institute of Cancer Research), Melanie Maranian(London School of Hygiene & Tropical Medicine), Shahana Ahmed(Amsterdam UMC Location Vrije Universiteit Amsterdam), Kristy Driver(Amsterdam UMC Location Vrije Universiteit Amsterdam), Nichola Johnson(Erasmus MC), Nicholas Orr(Erasmus MC), Isabel dos‐Santos‐Silva(Karolinska Institutet), Quinten Waisfisz(Karolinska Institutet), Hanne Meijers‐Heijboer(University of Helsinki), André G. Uitterlinden(Genome Institute of Singapore), Fernando Rivadeneira(University of Helsinki), Per Hall(University of Helsinki), Kamila Czene(University of Helsinki), Astrid Irwanto(Technical University of Munich), Jianjun Liu(University of Cologne), Heli Nevanlinna(Max Planck Institute of Psychiatry), Kristiina Aittomäki(Helmholtz Zentrum München), Carl Blomqvist(German Cancer Research Center), Alfons Meindl(German Cancer Research Center), Rita K. Schmutzler(German Cancer Research Center), Bertram Müller‐Myhsok(Universität Hamburg), Peter Lichtner(The University of Melbourne), Jenny Chang‐Claude(The University of Melbourne), Rebecca Hein(The University of Melbourne), Stefan Nickels(The University of Melbourne), Dieter Flesch‐Janys(The University of Melbourne), Helen Tsimiklis(The University of Melbourne), Enes Makalic(The University of Melbourne), Daniel F. Schmidt(The University of Melbourne), Minh Bui(Harvard University), John L. Hopper(National Cancer Institute), Carmel Apicella(The Netherlands Cancer Institute), Daniel J. Park(The Netherlands Cancer Institute), Melissa C. Southey(The Netherlands Cancer Institute), David J. Hunter(Universitätsklinikum Erlangen), Stephen J. Chanock(Universitätsklinikum Erlangen), Annegien Broeks(Universitätsklinikum Erlangen), Senno Verhoef(Friedrich-Alexander-Universität Erlangen-Nürnberg), Frans B.L. Hogervorst(National Health Service), Peter A. Fasching(Centre for Human Genetics), Michael P. Lux(University Hospital Galway), Matthias W. Beckmann(Heidelberg University), Arif B. Ekici(Heidelberg University), Elinor J. Sawyer(Heidelberg University), Ian Tomlinson(Heidelberg University), Michael J. Kerin(Inserm), Frederik Marmé(Inserm), Andreas Schneeweiß(Inserm), Christof Sohn(Inserm), Barbara Burwinkel(Herlev Hospital), Pascal Guénel(Herlev Hospital), Thérèse Truong(Herlev Hospital), Emilie Cordina‐Duverger(Herlev Hospital), F. Ménégaux(Spanish National Cancer Research Centre), Stig E. Bojesen(Spanish National Cancer Research Centre), Børge G. Nordestgaard(Spanish National Cancer Research Centre), Sune F. Nielsen(Spanish National Cancer Research Centre), Henrik Flyger(University of California, Irvine), Roger L. Milne(University of California, Irvine), M. Rosario Alonso(City of Hope), Anna González‐Neira(Cancer Prevention Institute of California), Javier Benı́tez(German Cancer Research Center), Hoda Anton‐Culver(German Cancer Research Center), Argyrios Ziogas(German Cancer Research Center), Leslie Bernstein(Krebsregister Saarland), Christina Clarke Dur(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Hermann Brenner(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Heiko Müller(Institute for Prevention and Occupational Medicine), Volker Arndt(Universität Ulm), Christa Stegmaier(German Cancer Research Center), Christina Justenhoven(Medizinische Hochschule Hannover), Hiltrud Brauch(Medizinische Hochschule Hannover), Thomas Brüning(Medizinische Hochschule Hannover), Shan Wang‐Gohrke(Medizinische Hochschule Hannover), Ursula Eilber(Medizinische Hochschule Hannover), Thilo Dörk(N.N. Alexandrov National Cancer Centre), Peter Schürmann(N.N. Alexandrov National Cancer Centre), Michael Bremer(Medizinische Hochschule Hannover), Peter Hillemanns(Russian Academy of Sciences), Natalia Bogdanova(Russian Academy of Sciences), Natalia Antonenkova(Russian Academy of Sciences), Yuriy Rogov(Karolinska Institutet), Johann H. Karstens(Karolinska Institutet), Marina Bermisheva(University of Eastern Finland), Darya Prokofieva(University of Eastern Finland), Э. К. Хуснутдинова(University of Eastern Finland), Annika Lindblom(University of Eastern Finland), Sara Margolin(Vlaams Instituut voor Biotechnologie), Arto Mannermaa(Vlaams Instituut voor Biotechnologie), Vesa Kataja, Veli‐Matti Kosma, Jaana M. Hartikainen(Fondazione IRCCS Istituto Nazionale dei Tumori), Diether Lambrechts(European Institute of Oncology), Betül T. Yesilyurt(IFOM), Giuseppe Floris(IFOM), Karin Leunen(Mayo Clinic), Siranoush Manoukian(Mayo Clinic), Bernardo Bonanni(Mayo Clinic in Florida), Stefano Fortuzzi(Mayo Clinic), Paolo Peterlongo(Cancer Council Victoria), Fergus J. Couch(Cancer Council Victoria), Xianshu Wang(Cancer Council Victoria), Kristen N. Stevens(The Alfred Hospital), Adam Lee(Oslo University Hospital), Graham G. Giles(Oslo University Hospital), Laura Baglietto(Oslo University Hospital), Gianluca Severi(Cancer Prevention Institute of California), Catriona McLean(Dana-Farber Cancer Institute), Grethe Grenaker Alnæs(Oulu University Hospital), Vessela N. Kristensen(Oulu University Hospital), Anne-Lise Børrensen-Dale(Oulu University Hospital), Esther M. John(Oulu University Hospital), Alexander Miron(Mount Sinai Hospital), Robert Winqvist(Cancer Care Ontario), Katri Pylkäs(University of Toronto), Arja Jukkola‐Vuorinen(Leiden University), Saila Kauppila(Leiden University), Irene L. Andrulis(Leiden University), Gord Glendon(Erasmus MC Cancer Institute), Anna Marie Mulligan(National Cancer Institute), Peter Devilee(Institute of Cancer Research), C. J. van Asperen(National Cancer Institute), Rob A.�E.�M. Tollenaar(The Maria Sklodowska-Curie National Research Institute of Oncology), Caroline Seynaeve(Erasmus MC), Jonine D. Figueroa(Erasmus MC), Montserrat García‐Closas(Erasmus MC), Louise A. Brinton(Erasmus MC), Jolanta Lissowska(University of Sheffield), Maartje J. Hooning(University of Sheffield), Antoinette Hollestelle(University of Cambridge), Rogier A. Oldenburg(International Hereditary Cancer Center), Ans M.W. van den Ouweland(International Hereditary Cancer Center), Angela Cox(International Hereditary Cancer Center), Malcolm Reed(International Hereditary Cancer Center), Mitul Shah(Institute of Cancer Research), Anna Jakubowska(Institute of Cancer Research), Jan Lubiński(Institute of Cancer Research), Katarzyna Jaworska(Institute of Cancer Research), Katarzyna Durda(QIMR Berghofer Medical Research Institute), Michael E. Jones(QIMR Berghofer Medical Research Institute), Minouk J. Schoemaker(University of Warwick), Alan Ashworth(University of Warwick), Anthony J. Swerdlow(Srinakharinwirot University), Jonathan Beesley(Ministry of Public Health), Xiaoqing Chen(Seoul National University), Kenneth Muir(Seoul National University), Artitaya Lophatananon(Seoul National University), Suthee Rattanamongkongul(Institute of Biomedical Sciences, Academia Sinica), Arkom Chaiwerawattana(Tri-Service General Hospital), Daehee Kang(Institute of Biomedical Sciences, Academia Sinica), Keun-Young Yoo(Institute of Biomedical Sciences, Academia Sinica), Dong‐Young Noh(Breast Cancer Now), Chen‐Yang Shen(Breast Cancer Now), Jyh‐Cherng Yu(Breast Cancer Now), Pei‐Ei Wu(University of Southampton), Chia‐Ni Hsiung(University of Southampton), Annie Perkins(University of Southampton), Ruth Swann(University of Southampton), Louiza S. Velentzis(University of Cambridge), Diana M Eccles(QIMR Berghofer Medical Research Institute), William Tapper(University of Cambridge), Susan M. Gerty(Centre National de Recherche en Génomique Humaine), Nikki Graham(University of Cambridge), Bruce A.J. Ponder(Institute of Cancer Research), Georgia Chenevix‐Trench(London School of Hygiene & Tropical Medicine), Paul D.P. Pharoah(University of Cambridge), Mark Lathrop, Alison M. Dunning, Nazneen Rahman, Julian Peto, Douglas F. Easton
Cited by 284Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis